Clearance Summary
SEFRIA Oxycodone Oral Fluid Enzyme Immunoassay received FDA 510(k) clearance under submission number K203564, sponsored by Immunalysis Corporation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Toxicology review panel. The statutory decision date of record is 2021-12-22.
- Submission: K203564
- Applicant / Sponsor: Immunalysis Corporation
- Clearance pathway: Traditional
- Review panel: Clinical Toxicology
- Device class: Class II
- Regulation citation: 21 CFR 862.3650
- Decision date: 2021-12-22
Classification & Regulation
This clearance is catalogued under FDA product code DJG and 21 CFR 862.3650, within the Clinical Toxicology review panel as a Class II device.